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ABSTRACT
Loss of vision associated with pulmonary hypertension in the pediatric age group has been rarely reported in the literature and often goes 
unnoticed for a long period. Pulmonary hypertension may manifest as shortness of breath limiting the activity of the individual, palpitation, 
headaches, easy fatiguability, dizziness been the most common symptoms encountered. However, primary pulmonary hypertension 
would not present itself instead secondary to other diseases like congenital heart disease, lung disease, connective tissue disorders or 
genetic diseases. Our case demonstrated a 17-year old individual with a primary complaint of progressive loss of vision in the left eye 
leading to complete vision loss. The patient experienced dyspnea two years back which exacerbated affecting his normal routine activity. 
His Echocardiography revealed severe pulmonary hypertension and was started on appropriate medications. His vision worsened and 
slit-lamp examination revealed multiple hemorrhages. Further investigations with FFA and OCT revealed significant hypoperfusion and 
significant elevation of the retina of the left eye. Anti-VEGF injections were given in an attempt to restore vision, but it resulted in no further 
improvement. Our case emphasizes the importance of prompt ophthalmologic examination in Pulmonary Hypertension.  
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INTRODUCTION
Pulmonary Hypertension is defined as increased 
pulmonary arterial pressure which in childhood 
presents even at rest [1]. Pulmonary Hypertension is a 
rare and life-threatening disease of both pediatric and 
adult age groups. The etiology of PH has been classi-
fied by the World Health Organization based on the 
mechanism of an underlying disease. However, the 
most common cause of Pulmonary Hypertension is 
Left Heart Failure. Untreated Pulmonary Hypertension 
leads ultimately to death [2]. Increased venous back 
pressures dilate the ocular veins, increasing the IOP 
increasing the risk of ciliary detachment, venous occlu-
sions and several other Ocular complications [2, 3]. 
Treatment of PAH is usually done systemically aimed 
to reduce Pulmonary Hypertension thereby reducing 
the risk of complications leading to organ damage . 
Ocular manifestations due to Pulmonary Hypertension 
has not been published extensively. We present the 
case of a patient who presented with loss of vision due 
to Central Retinal Vein Occlusion secondary to Pulmo-
nary Hypertension.
CASE PRESENTATION
We are presenting the case of a 17-year old male 
patient who presented in the Ophthalmology Out-
Patient department 4 weeks back with the complaint of 
a sudden loss of vision in the left eye. The patient 
experienced blurring of vision in the left eye more
compared to the right eye which gradually increased 
leading to complete loss of vision. It remained
unnoticed until the patient developed difficulty reading 
at school. On further questioning, it was revealed that 
the patient had developed dyspnea two years back. 
The patient never developed any symptoms at all 
before this event. The patient experienced a significant 
increase in dyspnea making him short of breath with 
little exertion. Family history revealed that a paternal 
female first cousin also has pulmonary hypertension 
which was detected a few years back.
On visual assessment, his best-corrected vision was 
6/12 OD and 1/60 OS without any further improvement 
on Snellen's Chart. Slit Lamp examination showed a 
normal anterior segment with a clear cornea, without 
any flares or cells, the pupil was round and regular with 
a normal lens as well as no cells in vitreous were 
visualized. The right eye fundus was normal with a 
normal optic disk and a healthy macula with the
vasculature. Whereas the left eye had a normal
anterior segment with a clear cornea however the 
fundus exam revealed pre-retinal and intraretinal
hemorrhages, dilated and tortuous veins and macular 
edema (Fig. 1A). Goldmann Applanation Tonometry 
was performed on a slit lamp and intra-ocular
pressures were found out to be within normal limits
in both eyes. To further investigate, a Fundus
Fluorescein Angiography with an SD-OCT was 
performed which showed normal right eye with normal 
retinal thickness and a normal FFA clear of
hemorrhages, or hypoperfusion (Fig. 1B). However, 
the left eye Fundus Fluorescein Angiography images 
revealed areas of hypoperfusion in all four quadrants 
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(Fig. 1C). SD-OCT of the left eye showed an
abnormally thick retina with significant elevation of the 
macula and with hemorrhages as well as areas of 
hypoperfusion were identified (Fig. 1D).
Fig. (1A): Fundus images showing a normal pattern in Right eye (OD). Fundus of Left eye (OS) depicting widespread Intra- Retinal
and Pre-Retinal Hemorrhages. OS= Left Eye, OD= Right Eye. Patient reviewed at Department of Ophthalmology, Dow University of Health 
Sciences, Ojha Campus, Karachi, Pakistan.
Fig. (1B): FFA images of the Right Eye.
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Fig. (1C): FFA images of the Left Eye depicting Intra and Pre- Retinal Hemorrhages and areas of hypoperfusion in all quadrants.
Fig. (1D): Spectral Domain- OCT; Right Eye (OD): Normal thickness Macula with intact Retina. Left Eye (OS): Increased thickness of retina 
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Laboratory investigations revealed normal routine lab 
results with a Hemoglobin level of 14.3g/dl and
hematocrit of 44%. Pediatric Transthoracic
Echocardiography (Fig. 2) showed severe Pulmonary 
Hypertension, Dilated IVC, Tricuspid Regurgitation, 
Right Ventricular Dilatation, and Enlarged Right Atrium, 
Moderate Pulmonary Regurgitation.
Given the presence of hemorrhages and areas of 
hypoperfusion in the left eye confirmed on Fundus
Fluorescein Angiography and SD-OCT (Fig. 1A-1D), a 
diagnosis of Central Retinal Vein Occlusion was made, 
and subsequent treatment was planned.
The patient is currently taking Sildenafil (PDE5
inhibitor), Bosentan (ET-1 Antagonist) and Spironolactone 
(Potassium-sparing diuretic). After the induction of
medications, his episodes of dyspnea improved significantly.
Treatment for the left eye was begun with Intra-Vitreal Avastin 
Injections. Three Intra-Vitreal Avastin Injections were given at 
regular intervals of one week apart. The patient was again 
examined after giving Intra-Vitreal Injections, but it did not 
improve the overall visual acuity as well as the
hemorrhages. Treatment with Acetazolamide 250mg BD was 
begun but it did not resolve his ocular symptoms either.
Fig. (2): Pediatric Transthoracic Echocardiography.
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DISCUSSION
Pulmonary Arterial Hypertension is a rare disease in 
infants and children with significant morbidity and 
mortality. In our case report, we have presented ocular 
findings that were found in a very young patient,
affecting his left eye that significantly deteriorated his 
visual acuity and is now limited to the only perception
of light. The symptoms experienced by patients
are non-specific including decreased vision,
metamorphopsia, and pain due to increased IOP as 
reported [2]. Causes of Pulmonary Hypertension include 
both familial as well as idiopathic type. Primary
pulmonary hypertension accounts for about 6% of all 
cases of pulmonary hypertension, and most of the 
reported ocular findings are associated with this subtype 
[2]. Austin et al. described the role of a genetic mutation 
that occurs in BMPR2 gene [4]. The pathophysiology of 
the disease reported has been vascular remodeling, 
lack of endothelin further exacerbated with underlying 
congenital heart disease. The significance of
considering a familial cause of it; is the presentation at
a younger age with gene anticipation observed in 
successive generations [1, 4].
Central Retinal Vein Occlusion, one of the feared
complications of Pulmonary Hypertension occurred 
unilaterally in our patient, a similar article highlighted the 
importance of managing it earlier on as it increased the 
chance of involving the fellow eye. Increased IOP 
results in compressing the central retinal vein
significantly [5]. Apart from CRVO our patient's OCT 
exhibited unusual Macular elevation deteriorating its 
normal architecture.
As Hammond et al. reported using acetazolamide which 
subsided macular edema and improved vision [6]. Given 
the unique nature of the ocular finding in our patient, we 
did use acetazolamide but to no resolve.
Most certainly it can be concluded that earlier diagnosis 
and systemic treatment in such a patient with pulmonary 
hypertension could avoid drastic complications.
CONCLUSION
Given the published evidence and thorugh experiences of 
different ophthalmologists around the world it is pertinent to 
say that such patients with pulmonary hypertension be 
referred to ophthalmologists early on to prevent loss of 
vision associated with it especially patients of pediatric age 
group, as our patient developed CRVO secondary to 
pulmonary hypertension.
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